<!DOCTYPE html SYSTEM "about:legacy-compat">
<html lang="en-US" class="no-js">
  <head>
    <meta charset="utf-8"/>
    <title>.05 Limitations. | Library of Maryland Regulations</title>
    <link rel="shortcut icon" href="/us/md/exec/_document/v2/images/favicons/favicon.ico"/>
    <!--Meta-->
    <meta http-equiv="X-UA-Compatible" content="IE=EDGE"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="HandheldFriendly" content="true"/>
    <meta itemprop="full-html" content="/us/md/exec/comar/10.09/index.full.html" data-document="href"/>
    <meta itemprop="toc-json" content="/us/md/exec/comar/10.09/index.json" data-document="href"/>
    <meta itemprop="parent-doc-url" content="/us/md/exec/comar" data-document="href"/>
    <meta itemprop="order" content="|10|09|03|.05|"/>
    <meta itemprop="doc-type" content="section" data-document=""/>
    <meta itemprop="ref-doc" content="Code of Maryland Regulations" data-document=""/>
    <meta itemprop="ref-path" content="10|09|03|.05" data-document=""/>
    <!--OpenGraph-->
    <meta property="og:url" content="/us/md/exec/comar/10.09.03.05"/>
    <meta property="og:type" content="article"/>
    <meta property="og:title" content=".05 Limitations. | Library of Maryland Regulations"/>
    <meta property="og:image" content="/us/md/exec/_document/v2/images/og/og_image.png"/>
    <!--Progressive Web App-->
    <link rel="manifest" href="/manifest.json"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="apple-mobile-web-app-status-bar-style" content="#0078EF"/>
    <meta name="apple-mobile-web-app-title" content="Library of Maryland Regulations"/>
    <meta name="theme-color" content="#0078EF"/>
    <meta name="apple-mobile-web-app-capable" content="yes"/>
    <meta name="mobile-web-app-capable" content="yes"/>
    <!--PWA icons-->
    <link rel="apple-touch-icon" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="60x60" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-60x60-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="76x76" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-76x76-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="152x152" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-152x152-precomposed.png"/>
    <link rel="apple-touch-icon-precomposed" sizes="180x180" href="/us/md/exec/_document/v2/images/favicons/apple-touch-icon-180x180-precomposed.png"/>
    <link rel="mask-icon" href="/us/md/exec/_document/v2/images/favicons/safari-pinned-tab.svg" color="#0078EF"/>
    <link rel="icon" type="image/png" sizes="16x16" href="/us/md/exec/_document/v2/images/favicons/favicon-16x16.png"/>
    <link rel="icon" type="image/png" sizes="32x32" href="/us/md/exec/_document/v2/images/favicons/favicon-32x32.png"/>
    <link rel="icon" type="image/png" sizes="48x48" href="/us/md/exec/_document/v2/images/favicons/favicon-48x48.png"/>
    <!--Fonts-->
    <link href="/us/md/exec/_document/v2/biticons/biticons.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/public-sans/public-sans.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/merriweather/merriweather.css" type="text/css" rel="stylesheet" data-document=""/>
    <link href="/us/md/exec/_document/v2/fonts/roboto-mono/roboto-mono.css" type="text/css" rel="stylesheet" data-document=""/>
    <!--Document CSS-->
    <link href="/us/md/exec/_document/v2/styles/responsive.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/main.min.css" type="text/css" rel="stylesheet" media="screen" data-document=""/>
    <link href="/us/md/exec/_document/v2/styles/print.min.css" type="text/css" rel="stylesheet" media="print" data-document=""/>
    <link href="/_reader/styles/main.min.css" type="text/css" rel="stylesheet"/>
    <script src="/_reader/js/main.js" data-document=""> </script>
    <!--Links to resources that need to be prefetched-->
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.full.html" as="fetch"/>
    <link rel="prefetch" href="/index.json" as="fetch"/>
    <link rel="prefetch" href="/us/md/exec/comar/10.09/index.json" as="fetch"/>
  </head>
  <body>
    <div role="region" id="announcer" aria-live="polite" class="sr-only" aria-atomic="true" aria-label="Live messages">
      <p id="message">Â </p>
    </div>
    <nav class="visually-hidden">
      <a href="#area__content" class="skip-link">Skip to main content</a>
    </nav>
    <div id="grid" class="ns__document__maryland-dsd">
      <header id="section__header" class="ns__document__maryland-dsd">
        <div id="section__header__inner" class="ns__document__maryland-dsd">
          <div id="area__logo" class="ns__document__maryland-dsd">
            <a href="/" class="logo" aria-label="Logo - Return to library home page">
              <img src="/us/md/exec/_document/v2/images/logo/logo.png" srcset="/us/md/exec/_document/v2/images/logo/logo.png 1x, /us/md/exec/_document/v2/images/logo/logo@2x.png 2x, /us/md/exec/_document/v2/images/logo/logo@3x.png 3x" alt="Library of Maryland Regulations logo"/>
            </a>
          </div>
          <div id="area__main_title" class="ns__document__maryland-dsd">
            <div class="h__library-logotype"><span class="line1">Library of</span> <span class="line2">Maryland Regulations</span></div>
          </div>
        </div>
      </header>
      <div id="section__content" class="ns__document__maryland-dsd">
        <div id="section__content__inner" class="ns__document__maryland-dsd">
          <section id="area__breadcrumbs" class="ns__document__maryland-dsd" role="region" aria-label="Breadcrumbs">
            <input type="checkbox" id="menu-trigger" class="menu-trigger" aria-label="Mobile menu toggler"/>
            <label for="menu-trigger">
              <span class="visually-hidden">Toggle mobile menu</span>
            </label>
            <nav role="navigation" aria-label="Breadcrumb navigation">
              <div class="h__ui">Navigation</div>
              <ul class="ancestors">
                <li data-search-path="library" data-search-heading="All Documents" class="no-indent">
                  <a href="/" title="Library of Maryland Regulations">Library of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations" data-search-heading="" data-search-default="true" class="li__book-open">
                  <a href="/us/md/exec/comar" title="Code of Maryland Regulations">Code of Maryland Regulations</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10" data-search-heading="">
                  <a href="/us/md/exec/comar/10" title="Title 10 MARYLAND DEPARTMENT OF HEALTH">Title 10 MARYLAND DEPARTMENT OF HEALTH</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09" title="Subtitle 09 MEDICAL CARE PROGRAMS">Subtitle 09 MEDICAL CARE PROGRAMS</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03" data-search-heading="">
                  <a href="/us/md/exec/comar/10.09.03" title="Chapter 03 Pharmacy Services">Chapter 03 Pharmacy Services</a>
                </li>
                <li data-search-path="library|Code of Maryland Regulations|10|09|03|.05" data-search-heading="">
                  <span title=".05 Limitations.">.05 Limitations.</span>
                </li>
              </ul>
            </nav>
          </section>
          <main id="area__content" class="ns__document__maryland-dsd">
            <div class="h__document-title">Code of Maryland Regulations</div>
            <article class="content" role="document" data-ref-path="10|09|03|.05">
              <div class="tuf-authenticate">
                <h1 class="h__toc" id="/us/md/exec/comar/10.09.03.05">.05 Limitations.</h1>
                <p class="text-indent-1 "><span class="level-num" id="A">A.</span> Except as specifically identified as being covered under <a class="internal-link " href="/us/md/exec/comar/10.09.03.04" title=".04 Covered Services.">Regulation .04 of this chapter</a>, the following are not covered:</p>
                <p class="text-indent-2 "><span class="level-num" id="A(1)">(1)</span> Nonlegend drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(2)">(2)</span> Medical supplies and durable equipment;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(3)">(3)</span> Any original prescription for a controlled substance dispensed more than 30 days after the date it was ordered;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(4)">(4)</span> Drugs supplied to hospital inpatients;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(5)">(5)</span> Drugs and supplies dispensed by the provider with an actual acquisition cost of $0;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(6)">(6)</span> Experimental or investigational drugs;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(7)">(7)</span> Except where authorized by the Department to be covered under this Regulation, injectables dispensed by a provider for administration by the prescriber;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(8)">(8)</span> Food supplements or infant formulas, including supplemental vitamin and mineral products when administered orally;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(9)">(9)</span> Sugar or salt substitutes;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(10)">(10)</span> Cosmetics, medicine chest supplies, and sundries including all soaps, all body powders, all body oils or body lotions, cotton balls, adhesive strip bandages, cotton-tipped applicators, suntan products, deodorants, dentifrices, tissues, convenience packages of covered items, hot water bottles, ice caps, heating pads, soft cervical collars;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(11)">(11)</span> Alcoholic beverages;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(12)">(12)</span> Ostomy supplies;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(13)">(13)</span> Those services authorized for payment to a prescriber, hospital, nursing facility, hospital outpatient department, or freestanding clinic;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(14)">(14)</span> Oral drugs or injections for central nervous system stimulants, anorexigenics, and any other agents when used for weight control;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(15)">(15)</span> Drug products for which federal financial participation is prohibited pursuant to 42 CFR Â§441.25;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(16)">(16)</span> Ovulation stimulants unless used to treat an iatrogenic infertility;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(17)">(17)</span> Effective January 1, 2006, any Part D drug for individuals who are eligible for Medicare Part D benefits;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(18)">(18)</span> Drugs or products used for hair growth or other cosmetic purposes;</p>
                <p class="text-indent-2 "><span class="level-num" id="A(19)">(19)</span> Any drug or supply that is covered and reimbursed by the Department under any other chapter of this subtitle; and</p>
                <p class="text-indent-2 "><span class="level-num" id="A(20)">(20)</span> Any drug or product the Department determines is not medically necessary.</p>
                <p class="text-indent-1 "><span class="level-num" id="B">B.</span> Prescriptions requiring preauthorization according to <a class="internal-link " href="/us/md/exec/comar/10.09.03.06" title=".06 Preauthorization Requirements.">Regulation .06 of this chapter</a> are not covered unless the required preauthorization has been obtained from the Department or its designee.</p>
                <p class="text-indent-1 "><span class="level-num" id="C">C.</span> Limitations on Covered Services.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(1)">(1)</span> The allowable cost of ingredients dispensed pursuant to a prescription may not exceed an upper limit as established in Regulation .07, of this chapter.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(2)">(2)</span> Refills.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(a)">(a)</span> The prescriber shall authorize refills only on the original prescription if the prescriber determines a refill is necessary and appropriate.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(b)">(b)</span> The Program may authorize no more than 11 refills, not to exceed other applicable federal and State limitations.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(2)(c)">(c)</span> The pharmacy may not automatically refill a prescription unless authorized in writing by the recipient or their designee.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(3)">(3)</span> Days Supply.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(a)">(a)</span> The total amount dispensed under one prescription order, including refills, is limited to a 360 days supply, not to exceed other applicable federal and State limitations.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(b)">(b)</span> Unless otherwise specified, prescriptions shall be limited to a 34 day supply at one time.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(c)">(c)</span> Unless otherwise specified, maintenance medication shall be limited to:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(c)(i)">(i)</span> A 34-day supply for the initial prescription; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(c)(ii)">(ii)</span> Up to a 100-day supply at one time for all subsequent prescriptions.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(d)">(d)</span> Prescriptions shall be dispensed at the lower of the quantity prescribed or the maximum days supply allowed at one time unless:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(d)(i)">(i)</span> The Program authorizes a reduction of the quantity; or</p>
                <p class="text-indent-4 "><span class="level-num" id="C(3)(d)(ii)">(ii)</span> The prescription is the final refill for the balance remaining on the total prescription order.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(e)">(e)</span> Providers may partially fill a prescription for Schedule II controlled dangerous substances, but the remaining portion of the prescription may not be later filled.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(f)">(f)</span> Oral sodium fluoride products used in the prevention of dental caries are limited to an original prescription of up to a 120-day supply with up to two refills, not to exceed a total of a 360-day supply.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(g)">(g)</span> Prescriptions for drugs packaged by the manufacturer as an unbreakable unit may be dispensed in increments of appropriate package size.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(3)(h)">(h)</span> Whether for an initial or subsequent prescription, contraceptive prescriptions may be dispensed in up to a 12 months supply at one time.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(4)">(4)</span> Generic Drugs.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(a)">(a)</span> Except as limited by Â§C(4)(b) and (c) of this regulation, when a drug product is prescribed by its nonproprietary or generic name, a provider shall substitute as follows:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(a)(i)">(i)</span> A drug product in the same strength, quantity, dose, and dosage form as the prescribed drug which is, in the providerâs professional opinion, therapeutically equivalent to the drug as prescribed; or</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(a)(ii)">(ii)</span> A drug product with the same generic name in the same strength, quantity, dose, and dosage form as the prescribed drug which is, in the providerâs professional opinion, bioequivalent to the drug as prescribed as rated by the U.S. Food and Drug Administration.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(b)">(b)</span> A provider may not substitute a generic drug for a brand name drug under <a class="internal-link " href="/us/md/exec/comar/10.09.03.05#C(4)(a)" title="">Â§C(4)(a) of this regulation</a> if:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(i)">(i)</span> The prescriber specifically directs otherwise; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(4)(b)(ii)">(ii)</span> The prescriber requests and received approval from the Program.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(4)(c)">(c)</span> The Department shall only authorize a provider to substitute a drug product under this regulation when there will be a savings in or no increase in cost to the Department.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(5)">(5)</span> Copayment for Services Rendered on or after July 1, 2005.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(a)">(a)</span> There will be no pharmacy copayment for prescriptions for the following:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(i)">(i)</span> Individuals younger than 21 years old;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(ii)">(ii)</span> Pregnant women;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(iii)">(iii)</span> Institutionalized individuals who are inpatients in long-term care facilities or other institutions requiring spending all but a minimal amount of income for medical costs;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(iv)">(iv)</span> Family planning drugs and devices; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(a)(v)">(v)</span> Individuals who are American Indians or Alaskan Natives.</p>
                <p class="text-indent-3 "><span class="level-num" id="C(5)(b)">(b)</span> The copayments for prescriptions not excluded from a copayment under <a class="internal-link " href="/us/md/exec/comar/10.09.03.05#C(5)(a)" title="">Â§C(5)(a) of this regulation</a> are:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(b)(i)">(i)</span> $3 for prescriptions for brand name drugs not on the preferred drug list;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(b)(ii)">(ii)</span> $1 for prescriptions for generic drugs and brand name drugs on the preferred drug list; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(5)(b)(iii)">(iii)</span> $1 for prescriptions for antiretroviral drugs in American Hospital Formulary Service therapeutic class 8:18:08.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(6)">(6)</span> Reimbursement may not be made:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(a)">(a)</span> For nonlegend enteric coated aspirin tablets in strengths other than 300 to 325 milligrams;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(b)">(b)</span> For any other nonlegend aspirin products such as sustained release capsules, buffered tablets, compressed tablets, liquid preparations or combination products in which aspirin is only one of the active ingredients;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(c)">(c)</span> For nonlegend ferrous sulfate products in strengths or dosage forms not listed in <a class="internal-link " href="/us/md/exec/comar/10.09.03.04#A(8)" title="">Regulation .04A(8) of this chapter</a>;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(d)">(d)</span> For nonlegend iron products combined with other active ingredients, except for chewable tablets as described in <a class="internal-link " href="/us/md/exec/comar/10.09.03.04#A(9)" title="">Regulation .04A(9) of this chapter</a>; or</p>
                <p class="text-indent-3 "><span class="level-num" id="C(6)(e)">(e)</span> At a reimbursement level which exceeds the maximum allowable cost established by the Program.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(7)">(7)</span> Condoms dispensed by pharmacy providers are subject to the following limitations:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(a)">(a)</span> The recipient shall present a Medical Assistance card with a current eligibility period;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(b)">(b)</span> Only 12 condoms may be dispensed to an individual at one time;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(c)">(c)</span> The provider may dispense condoms only to the individual named on the Medical Assistance card;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(d)">(d)</span> Natural membrane condoms are not covered; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(7)(e)">(e)</span> Both the recipient receiving the condoms and the provider shall sign the dispensing documentation.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(8)">(8)</span> A compounded prescription for intravenous therapy is subject to the following limitations:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(8)(a)">(a)</span> The Program may not cover a compounded prescription for intravenous therapy if a premixed, therapeutically equivalent commercial intravenous therapy is available from a commercial source;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(8)(b)">(b)</span> The Program may not cover the diluent component of a compounded prescription for intravenous therapy; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(8)(c)">(c)</span> All claims submitted require new prescription numbers.</p>
                <p class="text-indent-2 "><span class="level-num" id="C(9)">(9)</span> Prescriptions dispensed to participants residing in nursing facilities are subject to the following limitations:</p>
                <p class="text-indent-3 "><span class="level-num" id="C(9)(a)">(a)</span> Claims shall be identified as nursing facilities prescriptions by coding mechanisms determined by the Program;</p>
                <p class="text-indent-3 "><span class="level-num" id="C(9)(b)">(b)</span> Credits for unused unit dose medication and any other medication which may legally be returned to pharmacy stock:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(b)(i)">(i)</span> Shall be made within 60 days of Program payment;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(b)(ii)">(ii)</span> May not take into account any professional fee paid by the Program; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(b)(iii)">(iii)</span> Shall adjust for leave of absence prescriptions; and</p>
                <p class="text-indent-3 "><span class="level-num" id="C(9)(c)">(c)</span> Multiple prescriptions dispensed to a recipient residing in a nursing facility for the same drug product or compounded prescription shall receive only one professional fee per calendar month except for:</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(c)(i)">(i)</span> Leave of absence prescriptions;</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(c)(ii)">(ii)</span> Prescriptions for intravenous therapy; and</p>
                <p class="text-indent-4 "><span class="level-num" id="C(9)(c)(iii)">(iii)</span> Prescriptions for Schedule II-V controlled substances.</p>
                <p class="text-indent-1 "><span class="level-num" id="D">D.</span> Tamper Resistant Prescriptions.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(1)">(1)</span> Prescriptions written on or after April 1, 2008, that do not contain at least one of the tamper-resistant features as defined in Regulation .01B(34)(a) of this chapter are not covered.</p>
                <p class="text-indent-2 "><span class="level-num" id="D(2)">(2)</span> Prescriptions written on or after October 1, 2008, that do not contain all three tamper-resistant features as defined in Regulation .01B(34)(a) of this chapter are not covered.</p>
                <p class="text-indent-1 "><span class="level-num" id="E">E.</span> No covered drug or supply identified under <a class="internal-link " href="/us/md/exec/comar/10.09.03.04" title=".04 Covered Services.">Regulation .04 of this chapter</a> shall be reimbursed under <a class="internal-link " href="/us/md/exec/comar/10.09.03.07" title=".07 Payment Procedures.">Regulation .07 of this chapter</a> if:</p>
                <p class="text-indent-2 "><span class="level-num" id="E(1)">(1)</span> Federal financial participation from the Centers for Medicare &amp; Medicaid Services is not available for the drug or supply; or</p>
                <p class="text-indent-2 "><span class="level-num" id="E(2)">(2)</span> Prior authorization for the drug or supply is required under <a class="internal-link " href="/us/md/exec/comar/10.09.03.06" title=".06 Preauthorization Requirements.">Regulation .06 of this chapter</a> but was not obtained.</p>
              </div>
            </article>
          </main>
          <nav id="area__navigation_mini" class="ns__document__maryland-dsd" aria-label="Previous and next article links">
            <section>
              <a href="/us/md/exec/comar/10.09.03.04" aria-label=".04 Covered Services.">
                <div class="h__ui">Previous</div>
                <span>.04 Covered Services.</span>
              </a>
            </section>
            <section>
              <a href="/us/md/exec/comar/10.09.03.05-1" aria-label=".05-1 Expanded Limitations.">
                <div class="h__ui">Next</div>
                <span>.05-1 Expanded Limitations.</span>
              </a>
            </section>
          </nav>
        </div>
      </div>
      <footer id="section__footer" class="ns__document__maryland-dsd">
        <div id="section__footer__inner" class="ns__document__maryland-dsd">
          <div id="area__footer__content" class="ns__document__maryland-dsd">

<p>
      Please do not scrape. Instead, bulk download the CC-BY-SA <a href="https://github.com/maryland-dsd/law-html">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml">XML</a> or CC0 <a href="https://github.com/maryland-dsd/law-html-cc0">HTML</a> or <a href="https://github.com/maryland-dsd/law-xml-cc0">XML</a>.
    </p><p>Powered by the non-profit <a href="https://www.openlawlib.org/">Open Law Library</a>.</p></div>
        </div>
      </footer>
    </div>
    <!--Piwik analytics-->
    <noscript>
      <img src="/_analytics/pixel.png" style="border:0;" alt=""/>
    </noscript>
  </body>
</html>
